These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 6319301

  • 1. Phenotypic differentiation-linked growth inhibition in human leukemia cells by active vitamin D3 analogues.
    Matsui T, Nakao Y, Kobayashi N, Kishihara M, Ishizuka S, Watanabe S, Fujita T.
    Int J Cancer; 1984 Feb 15; 33(2):193-202. PubMed ID: 6319301
    [Abstract] [Full Text] [Related]

  • 2. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
    Mangelsdorf DJ, Koeffler HP, Donaldson CA, Pike JW, Haussler MR.
    J Cell Biol; 1984 Feb 15; 98(2):391-8. PubMed ID: 6319426
    [Abstract] [Full Text] [Related]

  • 3. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps.
    Inaba M, Okuno S, Koyama H, Nishizawa Y, Morii H.
    Arch Biochem Biophys; 1992 Feb 14; 293(1):181-6. PubMed ID: 1309983
    [Abstract] [Full Text] [Related]

  • 4. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
    Koizumi T, Nakao Y, Ishizuka S, Oshida J, Hara N, Ikekawa N, Fijita T.
    Arch Biochem Biophys; 1990 Feb 01; 276(2):310-6. PubMed ID: 2407190
    [Abstract] [Full Text] [Related]

  • 5. 1,25-Dihydroxyvitamin D3 regulates proliferation of activated T-lymphocyte subsets.
    Matsui T, Nakao Y, Koizumi T, Nakagawa T, Fujita T.
    Life Sci; 1985 Jul 08; 37(1):95-101. PubMed ID: 2989641
    [Abstract] [Full Text] [Related]

  • 6. Regulation of 25-hydroxyvitamin D3 metabolism in a human promyelocytic leukemia cell line (HL-60): 1,25-dihydroxyvitamin D3 stimulates the synthesis of 24,25-dihydroxyvitamin D3.
    Reichel H, Koeffler HP, Norman AW.
    Arch Biochem Biophys; 1986 Nov 15; 251(1):222-31. PubMed ID: 3024572
    [Abstract] [Full Text] [Related]

  • 7. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
    Miyaura C, Abe E, Suda T, Kuroki T.
    Cancer Res; 1985 Sep 15; 45(9):4244-8. PubMed ID: 2992776
    [Abstract] [Full Text] [Related]

  • 8. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Sep 15; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 9. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW, Zhou JY, Henry HL, Uskokovic MR, Koeffler HP.
    Cancer Res; 1990 Nov 01; 50(21):6857-64. PubMed ID: 2208153
    [Abstract] [Full Text] [Related]

  • 10. Reversibility of vitamin D-induced human leukemia cell-line maturation.
    Bar-Shavit Z, Kahn AJ, Stone KR, Trial J, Hilliard T, Reitsma PH, Teitelbaum SL.
    Endocrinology; 1986 Feb 01; 118(2):679-86. PubMed ID: 3753676
    [Abstract] [Full Text] [Related]

  • 11. Effects of calmodulin antagonists and cytochalasins on proliferation and differentiation of human promyelocytic leukemia cell line HL-60.
    Matsui T, Nakao Y, Kobayashi N, Koizumi T, Nakagawa T, Kishihara M, Fujita T.
    Cancer Res; 1985 Jan 01; 45(1):311-6. PubMed ID: 3855282
    [Abstract] [Full Text] [Related]

  • 12. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium.
    Itin PH, Pittelkow MR, Kumar R.
    Endocrinology; 1994 Nov 01; 135(5):1793-8. PubMed ID: 7956903
    [Abstract] [Full Text] [Related]

  • 13. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
    Yoshida M, Tanaka Y, Eguchi T, Ikekawa N, Saijo N.
    Anticancer Res; 1992 Nov 01; 12(6B):1947-52. PubMed ID: 1363510
    [Abstract] [Full Text] [Related]

  • 14. 1 alpha,25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes.
    Tanaka H, Abe E, Miyaura C, Shiina Y, Suda T.
    Biochem Biophys Res Commun; 1983 Nov 30; 117(1):86-92. PubMed ID: 6581807
    [Abstract] [Full Text] [Related]

  • 15. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
    Inaba M, Okuno S, Nishizawa Y, Yukioka K, Otani S, Matsui-Yuasa I, Morisawa S, DeLuca HF, Morii H.
    Arch Biochem Biophys; 1987 Nov 01; 258(2):421-5. PubMed ID: 2823715
    [Abstract] [Full Text] [Related]

  • 16. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
    Okuno S, Inaba M, Nishizawa Y, Morii H.
    Miner Electrolyte Metab; 1995 Nov 01; 21(1-3):211-6. PubMed ID: 7565452
    [Abstract] [Full Text] [Related]

  • 17. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
    Koeffler HP, Hirji K, Itri L.
    Cancer Treat Rep; 1985 Dec 01; 69(12):1399-407. PubMed ID: 2416438
    [Abstract] [Full Text] [Related]

  • 18. Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia.
    Abe J, Morikawa M, Miyamoto K, Kaiho S, Fukushima M, Miyaura C, Abe E, Suda T, Nishii Y.
    FEBS Lett; 1987 Dec 21; 226(1):58-62. PubMed ID: 2826255
    [Abstract] [Full Text] [Related]

  • 19. A dual block to cell cycle progression in HL60 cells exposed to analogues of vitamin D3.
    Godyn JJ, Xu H, Zhang F, Kolla S, Studzinski GP.
    Cell Prolif; 1994 Jan 21; 27(1):37-46. PubMed ID: 10465025
    [Abstract] [Full Text] [Related]

  • 20. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP.
    Cancer Res; 1996 Aug 01; 56(15):3570-6. PubMed ID: 8758928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.